Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis opticaÉdouard Januel, Pierre Labauge, Julie Pique et al.|Multiple Sclerosis Journal|2021Cited by 18
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisMathilde Lefort, F. Grand’Maison, Sifat Sharmin et al.|BMC Medical Research Methodology|2022Cited by 6